Omaveloxolone: potential new agent for Friedreich ataxia.

•  
• Overview
•  
• Research
•  
• Identity
•  
• Additional Document Info
•  
• View All
•  

Overview

authors

• David Lynch, MD, PhD
• Johnson, Joseph

publication date

• January 1, 2021

published in

• Neurodegenerative disease management  Journal

has subject area

• Friedreich Ataxia
• Humans
• Triterpenes

Research

Keywords

• Nrf2
• antioxidant response element
• ataxia
• cardiomyopathy
• glutathione
• reactive oxygen species
• scoliosis

Identity

Digital Object Identifier (DOI)

• https://doi.org/10.2217/nmt-2020-0057

PubMed ID

• 33430645

Additional Document Info

start page

• 91

end page

• 98

volume

• 11

issue

• 2